Receptor activator of nuclear factor kappa B ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis

Grimaud, E., Soubigou, L., Couillaud, S. et al. (6 more authors) (2003) Receptor activator of nuclear factor kappa B ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. The American Journal of Pathology, 163 (5). pp. 2021-2031. ISSN 0002-9440

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2003, American Society for Investigative Pathology
Dates:
  • Published: November 2003
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 25 Apr 2016 09:42
Last Modified: 25 Apr 2016 09:56
Published Version: http://dx.doi.org/10.1016/S0002-9440(10)63560-2
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/S0002-9440(10)63560-2
Related URLs:

Share / Export

Statistics